Filing Details

Accession Number:
0001127602-17-020675
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-06 16:26:36
Reporting Period:
2017-06-02
Filing Date:
2017-06-06
Accepted Time:
2017-06-06 16:26:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859737 Hologic Inc HOLX X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042902449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190290 Elaine Ullian 250 Campus Drive
Marlborough MA 01752
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-05-16 1,444 $0.00 23,810 No 5 G Direct
Common Stock Acquisiton 2017-06-02 8,938 $32.82 32,748 No 4 M Direct
Common Stock Disposition 2017-06-02 8,938 $43.99 23,810 No 4 S Direct
Common Stock Acquisiton 2017-06-05 1,362 $32.82 25,172 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2017-06-02 8,938 $0.00 8,938 $32.82
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2017-06-05 1,362 $0.00 1,362 $32.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,562 2017-10-22 No 4 M Direct
18,200 2017-10-22 No 4 M Direct
Footnotes
  1. The Reporting Person voluntarily transferred 722 shares of common stock to each of the irrevocable Ullian Family 2014 GST Trust and the irrevocable Ullian Family Health and Education Trust for a total of 1,444 shares.
  2. Transaction pursuant to an existing rule 10b5-1 trading plan.
  3. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $43.22 to $44.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  4. Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan.
  5. This option became fully vested on 10/22/2007.